Vector Models and Indexing for Bioequivalence Pharmacovigilance

Bioequivalence study data primarily originates from clinical trial reports, pharmaceutical research reports, and bioanalytical reports. This data has

Data Characteristics in this Domain

Bioequivalence study data primarily originates from clinical trial reports, pharmaceutical research reports, and bioanalytical reports. This data has a relatively low update frequency, with new batches typically generated only during drug approval applications or significant changes. Documents exist in both structured and semi-structured formats, including clinical study protocols, subject screening records, raw plasma concentration-time curve data, and statistical analysis reports. Key fields include drug name, active ingredient, dosage form, administration route, subject characteristics (e.g., age, sex, weight), maximum plasma concentration (Cmax), time to maximum concentration (Tmax), area under the curve (AUC), and adverse event descriptions and severity. Units are predominantly SI units; for example, plasma concentration is often expressed in ng/mL or μg/mL, and time in hours or minutes.

Constraints Imposed by these Characteristics on Vector Models and Indexing

The low update frequency of bioequivalence data means that knowledge base reconstruction or incremental indexing operations do not need to be overly frequent. The diversity of document structures requires vector models to effectively process information in different formats, especially extracting key numerical values and descriptive text from semi-structured reports. Numerical fields such as plasma concentration and AUC need appropriate normalization or specialized numerical embedding techniques to enhance their semantic representation capabilities. Adverse event descriptions often contain medical terminology and natural language, which demands strong semantic understanding from vector models. During index construction, the focus should be on precise recall of key bioequivalence parameters and adverse reaction events, avoiding interference from irrelevant information due to large data volumes. Additionally, given the sensitive nature of the data, ensuring data security and compliance during the indexing process is crucial.

Configuration Guidelines

Configuration ItemRecommended ValueRationale
Chunk size (Chunk Size)800–1200 charactersBalances contextual completeness with vector model processing capabilities, preventing information overload in a single chunk.
Chunk Overlap Length (Chunk Overlap)100–200 charactersEnsures semantic continuity at chunk boundaries, improving recall accuracy.
embeddingModelCalibrated by measurementSelection based on coverage of biomedical terminology and multilingual support capabilities.
Recall count (Recall Count)Top 8–12 itemsBalances recall breadth with subsequent re-ranking efficiency, ensuring key information is covered.
Similarity threshold (Similarity Threshold)0.75–0.85Filters low-quality results while maintaining relevance, considering domain-specific characteristics.
Indexing StrategyFull ReconstructionGiven the low data update frequency and high integrity requirements, full reconstruction ensures index consistency.

Three Common Pitfalls

  • Knowledge base queries return too few or irrelevant results, typically due to a Similarity threshold (Similarity Threshold) set too high, which strictly filters out potentially relevant but slightly less similar results.
  • Uploading large bioequivalence report files results in prolonged unresponsiveness or processing failure. This may be related to a PARSE_FILE_TIMEOUT_SECONDS parameter value that is too low, not allowing the parser sufficient time to process complex documents.
  • After updating some bioequivalence data, query results still show old information. This often happens because the knowledge base's incremental indexing or full reconstruction operation was not triggered in a timely manner.

How to Verify Correct Configuration

  • Upload a report containing typical bioequivalence parameters and adverse events. Query with keywords strongly related to the report content. Observe whether the recall results accurately include key numerical values and descriptions from the report, and check if the Recall count (Recall Count) meets expectations.
  • Use a report with known adverse reaction information for querying. Adjust the Similarity threshold (Similarity Threshold) and observe changes in the relevance and quantity of recall results until a balance is found that recalls key information while filtering out irrelevant information.
  • Check the knowledge base's index status logs to confirm that after each data update, indexing operations (e.g., incremental indexing or full reconstruction) completed successfully, and no parsing failures or timeouts occurred.

Note: The values provided are common starting points. It is recommended to measure and adjust these parameters against your own data samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.